202 related articles for article (PubMed ID: 18587010)
1. Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia.
Carobbio A; Finazzi G; Antonioli E; Guglielmelli P; Vannucchi AM; Delaini F; Guerini V; Ruggeri M; Rodeghiero F; Rambaldi A; Barbui T
Blood; 2008 Oct; 112(8):3135-7. PubMed ID: 18587010
[TBL] [Abstract][Full Text] [Related]
2. Leukocytosis and risk stratification assessment in essential thrombocythemia.
Carobbio A; Antonioli E; Guglielmelli P; Vannucchi AM; Delaini F; Guerini V; Finazzi G; Rambaldi A; Barbui T
J Clin Oncol; 2008 Jun; 26(16):2732-6. PubMed ID: 18443353
[TBL] [Abstract][Full Text] [Related]
3. Platelet count in essential thrombocythemia: the more the better?
Tefferi A
Blood; 2008 Oct; 112(8):3526; author reply 3526-7. PubMed ID: 18840727
[No Abstract] [Full Text] [Related]
4. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status.
Carobbio A; Finazzi G; Guerini V; Spinelli O; Delaini F; Marchioli R; Borrelli G; Rambaldi A; Barbui T
Blood; 2007 Mar; 109(6):2310-3. PubMed ID: 17110452
[TBL] [Abstract][Full Text] [Related]
5. The association of JAK2V617F mutation and leukocytosis with thrombotic events in essential thrombocythemia.
Hsiao HH; Yang MY; Liu YC; Lee CP; Yang WC; Liu TC; Chang CS; Lin SF
Exp Hematol; 2007 Nov; 35(11):1704-7. PubMed ID: 17920754
[TBL] [Abstract][Full Text] [Related]
6. Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.
Stalder G; Da Silva WR; Segot A; Blum S; Grandoni F; Alberio L
Eur J Intern Med; 2023 Jan; 107():110-112. PubMed ID: 36117085
[No Abstract] [Full Text] [Related]
7. Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms.
Gugliotta L; Iurlo A; Gugliotta G; Tieghi A; Specchia G; Gaidano G; Scalzulli PR; Rumi E; Dragani A; Martinelli V; Santoro C; Randi ML; Tagariello G; Candoni A; Cattaneo D; Ricco A; Palmieri R; Liberati MA; Langella M; Rago A; Bergamaschi M; Monari P; Miglio R; Santoro U; Cacciola R; Rupoli S; Mastrullo L; Musto P; Mazzucconi MG; Vignetti M; Cortelezzi A; Vianelli N; Martino B; De Stefano V; Passamonti F; Vannucchi AM;
Leuk Res; 2016 Jul; 46():18-25. PubMed ID: 27107744
[TBL] [Abstract][Full Text] [Related]
8. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
Tefferi A; Barbui T
Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Broseus J; Florensa L; Zipperer E; Schnittger S; Malcovati L; Richebourg S; Lippert E; Cermak J; Evans J; Mounier M; Raya JM; Bailly F; Gattermann N; Haferlach T; Garand R; Allou K; Besses C; Germing U; Haferlach C; Travaglino E; Luno E; Pinan MA; Arenillas L; Rozman M; Perez Sirvent ML; Favre B; Guy J; Alonso E; Ahwij N; Jerez A; Hermouet S; Maynadié M; Cazzola M; Girodon F
Haematologica; 2012 Jul; 97(7):1036-41. PubMed ID: 22532522
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
Alvarez-Larrán A; Pereira A; Guglielmelli P; Hernández-Boluda JC; Arellano-Rodrigo E; Ferrer-Marín F; Samah A; Griesshammer M; Kerguelen A; Andreasson B; Burgaleta C; Schwarz J; García-Gutiérrez V; Ayala R; Barba P; Gómez-Casares MT; Paoli C; Drexler B; Zweegman S; McMullin MF; Samuelsson J; Harrison C; Cervantes F; Vannucchi AM; Besses C
Haematologica; 2016 Aug; 101(8):926-31. PubMed ID: 27175028
[TBL] [Abstract][Full Text] [Related]
11. Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.
Palandri F; Polverelli N; Catani L; Ottaviani E; Baccarani M; Vianelli N
Ann Hematol; 2011 Aug; 90(8):933-8. PubMed ID: 21287350
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
Barbui T; Carobbio A; Rambaldi A; Finazzi G
Blood; 2009 Jul; 114(4):759-63. PubMed ID: 19372254
[TBL] [Abstract][Full Text] [Related]
13. Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.
Ohyashiki K; Kiguchi T; Ito Y; Fujimoto H; Gotoh A; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
Int J Hematol; 2008 May; 87(4):446-448. PubMed ID: 18409076
[No Abstract] [Full Text] [Related]
14. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
[TBL] [Abstract][Full Text] [Related]
15. Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?
Tefferi A; Gangat N; Wolanskyj AP
Blood; 2006 Oct; 108(7):2493-4. PubMed ID: 16988161
[No Abstract] [Full Text] [Related]
16. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
Turakhia SK; Murugesan G; Cotta CV; Theil KS
J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia.
Michiels JJ
Clin Appl Thromb Hemost; 1999 Oct; 5(4):247-51. PubMed ID: 10726022
[TBL] [Abstract][Full Text] [Related]
18. Essential thrombocythemia: a hypercoagulable state.
Hunter Mellado RF; Oppenheimer Catalá J; Vázquez Medina J
Bol Asoc Med P R; 1991 Oct; 83(10):436-9. PubMed ID: 1789889
[TBL] [Abstract][Full Text] [Related]
19. [Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients].
Angona A; Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Garcia-Pallarols F; Longarón R; Ancochea À; Besses C
Med Clin (Barc); 2015 Mar; 144(6):247-53. PubMed ID: 25192581
[TBL] [Abstract][Full Text] [Related]
20. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
Gangat N; Wolanskyj AP; Schwager SM; Hanson CA; Tefferi A
Cancer; 2009 Dec; 115(24):5740-5. PubMed ID: 19806641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
